USPTO serial 88179774
LTS SMART
Reviewed by CopyMark Law Group
Reg. 5993702Status 710
- Filing date
- Status date
- Registration date
- Feb 25, 2020
- Examiner
- EULIN, INGRID C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with LTS SMART?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
LTS Lohmann Therapie-Systeme AG
Andernach, DE
LTS Lohmann Therapie-Systeme AG
Andernach, DE
LTS Lohmann Therapie-Systeme AG
Andernach, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kirk M. Miles, Registration No. 37,891
Kirk M. Miles, Registration No. 37,891 THE WEBB LAW FIRM420 FORT DUQUESNE BOULEVARD, SUITE 1200ONE GATEWAY CENTERPITTSBURGH, PA 15222Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry; chemicals used in science; injection preparations for needle-free injection, for injection by means of needles, or injection by cannula systems, namely, chemicals for use in agriculture, horticulture, and in forestry, except fungicides, herbicides, insecticides and parasiticides, the aforesaid products and injection preparations being for livestock farming or animal breeding, including aquaculture | SECTION 8 - CANCELLED | — |
| 005 | Pharmaceutical and veterinary preparations, namely, injectable pharmaceutical and veterinary preparations for the prevention and treatment of disease, namely, infectious diseases, viral diseases, pain and chronic pain, neurological diseases, central nervous system diseases, brain diseases, oral and dental diseases, inflammatory diseases, immune system diseases, dermatological diseases, sexually transmitted diseases, musculoskeletal diseases, cosmetic procedures and diseases, psychiatric diseases, diseases of the spinal cord and motor disorders, cardiovascular diseases, diseases of the respiratory system, diseases treated by oncologists, gastroenterologists, opthalmologists, otologists, audolaryngologists, gynecologists, gerontologists, proctologists, and urologists by intracutaneous, intradermal, subcutaneous, intramuscular, intravenous and intra-articular injection, the aforesaid injection preparations being for needle-free injection or for injection by means of needle or cannula systems; injectable pharmaceutical and veterinary preparation therapeutic or prophylactic ingredients or diagnostic preparations, namely, pharmaceutical and therapeutic preparations for use with pets, laboratory animals, wild animals, zoo animals and livestock, including aquaculture, for the treatment and prevention of disease, namely, infectious diseases, viral diseases, pain and chronic pain, neurological diseases, central nervous system diseases, brain diseases, oral and dental diseases, inflammatory diseases, immune system diseases, dermatological diseases, sexually transmitted diseases, musculoskeletal diseases, cosmetic procedures and diseases, psychiatric diseases, diseases of the spinal cord and motor disorders, cardiovascular diseases, diseases of the respiratory system, diseases treated by oncologists, gastroenterologists, opthalmologists, otologists, audolaryngologists, gynecologists, gerontologists, proctologists, and urologists; preparations for destroying vermin; fungicides; herbicides; pharmaceuticals for use in the gastrointestinal tract, subcutaneous use and for oral use for the treatment and prevention of disease, namely, infectious diseases, viral diseases, pain and chronic pain, neurological diseases, central nervous system diseases, brain diseases, oral and dental diseases, inflammatory diseases, immune system diseases, dermatological diseases, sexually transmitted diseases, musculoskeletal diseases, cosmetic procedures and diseases, psychiatric diseases, diseases of the spinal cord and motor disorders, cardiovascular diseases, diseases of the respiratory system, diseases treated by oncologists, gastroenterologists, opthalmologists, otologists, audolaryngologists, gynecologists, gerontologists, proctologists, and urologists; medicines for administration in the form of plasters and wafers containing active ingredients, namely, medicines for the treatment of gastrointestinal diseases; medical plasters containing active ingredients for transdermal administration of active ingredients, medical plasters containing active ingredients for topical processing of active ingredients, and for manufacturing active ingredient-free laminates | SECTION 8 - CANCELLED | — |
| 010 | Surgical, medical, dental and veterinary instruments and apparatus, namely, instruments and apparatus for injecting substances, in particular infusion and injection device for administering drugs, needle-free, via needles, by cannulae, or through an injection systems comprised primarily of a needle-free injection device, ampoules, storage bottles and accessories for injection devices; dropper bottle for administering medication, sold empty; medicine delivery devices and instruments, namely, microneedles and/or microneedle assemblies or structures for use in dermal, transdermal, mucosal and transmucosal administration of pharmaceuticals and biotechnological molecules; medicine delivery devices and instruments, namely, microneedles and/or microneedle assemblies for use in dermal, transdermal, mucosal and transmucosal sampling of bodily fluids; medical devices and instruments for administering pharmaceuticals and biotechnological molecules using needle-like microstructures, plaster needles for medical purposes for use on the skin; injection device for pharmaceuticals, namely, medical injection device for administering drugs; parts for the aforesaid goods, in particular microneedles and/or microneedle assemblies for use in administering pharmaceuticals and biotechnological molecules | SECTION 8 - CANCELLED | — |
| 020 | Nonmetal and non-paper containers for storage or transport of injection devices consisting of needle-free injection systems or systems for injection using needles or cannulae, medical products | SECTION 8 - CANCELLED | — |
| 021 | Ampoules for medication sold empty | SECTION 8 - CANCELLED | — |
| 042 | Scientific and technological services and research, namely, development of pharmaceuticals veterinary preparations and medicines, up to the production stage; conducting of analytical testing of pharmaceuticals and veterinary preparations; new product design with respect to health care products in the nature of pharmaceutical and veterinary preparations; industrial analysis and research, namely, testing, analysis and evaluation of injection devices and injection systems, in particular needle-free injection systems or systems for injection using needles or cannulae and the dermal, transdermal, mucosal and transmucosal administration of pharmaceuticals and biotechnological molecules of others to assure compliance with industry standards; design and development of computer hardware and software | SECTION 8 - CANCELLED | — |
| 044 | Medical services; veterinary services; pharmaceutical consultation; hygienic care for human beings; beauty care for human beings; animal healthcare services, namely, veterinary services; animal beautician services, namely, pet grooming services; agriculture services, namely, compost spreading; horticultural services; forestry, namely, insecticide spraying for forestry; all of the aforesaid in the field of injection devices and injection systems, in particular needle-free injection systems or systems for injection using needles or cannulae; medical consultations for patients and qualified personnel, in particular doctors, in relation to medicine delivery systems and instruments, in particular comprising microneedles and/or microneedle assemblies or structures for use in dermal, transdermal, mucosal and transmucosal administration of pharmaceuticals and biotechnological molecules; preparation and administration of medicines, including by means of plasters for use on the skin, namely, preparation of prescriptions by pharmacists | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LTS Lohmann Therapie-Systeme AG
- Other trademarks owned by LTS Lohmann Therapie-Systeme AG
- Other trademarks owned by LTS Lohmann Therapie-Systeme AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 020
- Other trademarks in Class 021
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named LTS SMART
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 4, 2026 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Feb 25, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Feb 25, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 10, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 10, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 20, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 4, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 4, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 4, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 4, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 4, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 31, 2019 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Oct 31, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 29, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 29, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 28, 2019 | ALIE | ASSIGNED TO LIE | — |
| Oct 22, 2019 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Aug 12, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Aug 12, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Aug 12, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Aug 10, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 9, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 9, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 11, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 11, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 11, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 8, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 18, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 6, 2018 | NWAP | NEW APPLICATION ENTERED | — |